StockSelector.com
  Research, Select, & Monitor Saturday, March 28, 2020 5:51:27 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup

Market Movers
Technicals
Valuations
Growth
  Estimated Earnings
  Historic Earnings
  Estimated Revenue
  Historic Revenue
  Cash
  Dividend
  Shares
Fundamentals
Stock Options

CATALYST PHARMACEUTICALS, INC. CPRX 20,362.00% N/A

CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for Brookhaven's patent portfolio in the US relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending worldwide. The Company's initial product candidate based on vigabatrin is CPP-109. CPP-109 has been granted Fast Track status by the U.S. Food & Drug Administration for the treatment of cocaine addiction. This indicates that the FDA has recognized that CPP-109 is intended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs.
Company Ticker History Revenue Growth History Growth Rate
Zai Lab Limited ZLAB 9,884.62% N/A
Regulus Therapeutics Inc. RGLS 9,657.14% N/A
CRISPR THERAPTC CRSP 9,181.73% N/A
Stemline Therapeutics, Inc. STML 8,544.00% N/A
Clearside BioMedical, Inc CLSD 7,133.33% N/A
Legal & General Group Plc 10p LGGNY 4,954.63% 2.63%
Arena Pharmaceuticals, Inc. ARNA 4,387.65% N/A
Wrap Technologies, Inc. WRTC 3,400.00% N/A
Calyxt, Inc. CLXT 2,941.67% N/A
Axonics Modulation Technologies, Inc. AXNX 1,846.48% N/A
Insmed, Inc. INSM 1,286.89% N/A
Voyager Therapeutics, Inc. VYGR 1,269.95% N/A
KAZIA THERAPTCS KZIA 1,144.44% N/A
EXICURE INC XCUR 983.33% N/A
Arrowhead Pharmaceuticals, Inc. ARWR 945.85% N/A
Mediwound Ltd. MDWD 835.00% N/A
Sunesis Pharmaceuticals Inc SNSS 762.50% N/A
CleanSpark, Inc. CLSK 681.03% N/A
Akcea Therapeutics, Inc. AKCA 653.11% N/A
Corbus Pharmaceuticals Holdings, Inc. CRBP 649.79% N/A
Selecta Biosciences, Inc. SELB 642.22% N/A
Bellicum Pharmaceuticals, Inc. BLCM 537.50% N/A
Alithya Group inc. ALYA 535.43% N/A
OrganiGram OGI 523.43% (57.14%)
Antero Midstream Llc AM 454.61% 278.79%
Translate Bio TBIO 449.30% N/A
Forestar Group Inc. FOR 446.86% N/A
AVEO Pharmaceuticals Inc AVEO 432.35% N/A
Acceleron Pharma Inc XLRN 428.88% N/A
GSX Techedu Inc. GSX 413.14% N/A
Lexicon Pharmaceuticals Inc LXRX 409.52% N/A
MORPHIC HLDG MORF 405.36% N/A
Green Organic Dutchman Holdings Ltd. TGODF 400.60% N/A
Optinose, Inc. OPTN 389.82% N/A
New Age Beverages Corporation NBEV 386.41% N/A


Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.